Covid-19 vaccine reports are on the horizon, with drugmakers including Pfizer Inc. expected to obtain more trial data as early as this week.
The updates are eagerly awaited as the pandemic accelerates, with the U.S. surpassing 11 million cases.More data from vaccine creator Moderna Inc.
is expected in the coming days, while AstraZeneca and its partner, the University of Oxford, may also have preliminary results in the next few weeks.Johnson & Johnson has launched a new large-scale late-stage trial today to test a two-dose regimen of its experimental COVID-19 vaccine and evaluate potential incremental benefits for the duration of protection with a second dose.The U.S.